Christopher Lucas

Dr. Christopher Lucas

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2014 in Nature Reviews Immunology
Verified
Journal Article
Open access
PDF file
Ivan PoonIvan Poon
Ivan Poon
CLChristopher Lucas
Christopher Lucas
ARAdriano G. Rossi
Adriano G. Rossi
KRKodi S. Ravichandran
Kodi S. Ravichandran
Apoptotic cells are rapidly removed by tissue-resident professional phagocytes and/or by neighbouring non-professional phagocytes under homeostatic conditions. The prompt clearance of apoptotic cells involves molecular steps that include the recruitment of phagocytes towards apoptotic cells through 'find-me' signals and the recognition of 'eat-me' signals on apoptotic cells that trigger engulfment. Apoptotic cell clearance under physiological conditions is generally anti-inflammatory and immunologically silent. Defects in apoptotic cell removal are associated with the initiation and progression of a number of pathological conditions, including inflammation and autoimmunity. The process of apoptotic cell clearance can be manipulated potentially by pharmacological means to treat a variety of human diseases.

15 January 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
DDDavid Dorward
David Dorward
CRClark D. Russell
Clark D. Russell
IUIn Hwa Um
In Hwa Um
MEMustafa Elshani
Mustafa Elshani
SAStuart Armstrong
Stuart Armstrong
OCon behalf of the ICECAP consortium
on behalf of the ICECAP consortium
Rationale: In life-threatening coronavirus disease (COVID-19), corticosteroids reduce mortality, suggesting that immune responses have a causal role in death. Whether this deleterious inflammation is primarily a direct reaction to the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or an independent immunopathologic process is unknown. Objectives: To determine SARS-CoV-2 organotropism and organ-specific inflammatory responses and the relationships among viral presence, inflammation, and organ injury. Methods: Tissue was acquired from 11 detailed postmortem examinations. SARS-CoV-2 organotropism was mapped by using multiplex PCR and sequencing, with cellular resolution achieved by in situ viral S (spike) protein detection. Histologic evidence of inflammation was quantified from 37 anatomic sites, and the pulmonary immune response was characterized by using multiplex immunofluorescence. Measurements and Main Results: Multiple aberrant immune responses in fatal COVID-19 were found, principally involving the lung and reticuloendothelial system, and these were not clearly topologically associated with the virus. Inflammation and organ dysfunction did not map to the tissue and cellular distribution of SARS-CoV-2 RNA and protein between or within tissues. An arteritis was identified in the lung, which was further characterized as a monocyte/myeloid-rich vasculitis, and occurred together with an influx of macrophage/monocyte-lineage cells into the pulmonary parenchyma. In addition, stereotyped abnormal reticuloendothelial responses, including excessive reactive plasmacytosis and iron-laden macrophages, were present and dissociated from viral presence in lymphoid tissues. Conclusions: Tissue-specific immunopathology occurs in COVID-19, implicating a significant component of the immune-mediated, virus-independent immunopathologic process as a primary mechanism in severe disease. Our data highlight novel immunopathologic mechanisms and validate ongoing and future efforts to therapeutically target aberrant macrophage and plasma-cell responses as well as promote pathogen tolerance in COVID-19.

1 May 2015 in The American Journal of Pathology
Verified
Journal Article
Open access
DDDavid Dorward
David Dorward
CLChristopher Lucas
Christopher Lucas
GCGavin B. Chapman
Gavin B. Chapman
CHChristopher Haslett
Christopher Haslett
KDKevin Dhaliwal
Kevin Dhaliwal
ARAdriano G. Rossi
Adriano G. Rossi
Neutrophil migration to sites of inflammation and the subsequent execution of multiple functions are designed to contain and kill invading pathogens. These highly regulated and orchestrated processes are controlled by interactions between numerous receptors and their cognate ligands. Unraveling and identifying those that are central to inflammatory processes may represent novel therapeutic targets for the treatment of neutrophil-dominant inflammatory disorders in which dysregulated neutrophil recruitment, function, and elimination serve to potentiate rather than resolve an initial inflammatory insult. The first G protein-coupled receptor to be described on human neutrophils, formyl peptide receptor 1 (FPR1), is one such receptor that plays a significant role in the execution of these functions through multiple intracellular signaling pathways. Recent work has highlighted important observations with regard to both receptor function and the importance and functional relevance of FPR1 in the pathogenesis of a range of both sterile and infective inflammatory conditions. In this review, we explore the multiple components of neutrophil migration and function in both health and disease, with a focus on the role of FPR1 in these processes. The current understanding of FPR1 structure, function, and signaling is examined, alongside discussion of the potential importance of FPR1 in inflammatory diseases suggesting that FPR1 is a key regulator of the inflammatory environment.

20 December 2018 in The Journal of Pathology
Verified
Journal Article
Open access
PDF file
PPPhilippe M.D. Potey
Philippe M.D. Potey
ARAdriano G. Rossi
Adriano G. Rossi
CLChristopher Lucas
Christopher Lucas
DDDavid Dorward
David Dorward
Acute respiratory distress syndrome (ARDS) is the often fatal sequelae of a broad range of precipitating conditions. Despite decades of intensive research and clinical trials there remain no therapies in routine clinical practice that target the dysregulated and overwhelming inflammatory response that characterises ARDS. Neutrophils play a central role in the initiation, propagation and resolution of this complex inflammatory environment by migrating into the lung and executing a variety of pro‐inflammatory functions. These include degranulation with liberation of bactericidal proteins, release of cytokines and reactive oxygen species as well as production of neutrophil extracellular traps. Although these functions are advantageous in clearing bacterial infection, the consequence of associated tissue damage, the contribution to worsening acute inflammation and prolonged neutrophil lifespan at sites of inflammation are deleterious. In this review, the importance of the neutrophil will be considered, together with discussion of recent advances in understanding neutrophil function and the factors that influence them throughout the phases of inflammation in ARDS. From a better understanding of neutrophils in this context, potential therapeutic targets are identified and discussed. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

1 January 2013 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
RGRobert D. Gray
Robert D. Gray
CLChristopher Lucas
Christopher Lucas
AMAnnie MacKellar
Annie MacKellar
FLFeng Li
Feng Li
KHKatia Hiersemenzel
Katia Hiersemenzel
Adriano RossiAdriano Rossi
Adriano Rossi
Activation of NADPH oxidase is required for neutrophil extracellular trap (NET) formation. Protein kinase C (PKC) is an upstream mediator of NADPH oxidase activation and thus likely to have a role in NET formation. Pharmacological inhibitors were used to block PKC activity in neutrophils harvested from healthy donor blood. Pan PKC inhibition with Ro-31-8220 (p<0.001), conventional PKC inhibition with Go 6976 (p<0.001) and specific PKCβ inhibition with LY333531 (p<0.01) blocked NET formation in response to PMA. Inhibition of novel and atypical PKC had no effect. LY333531 blocked NET induction by the diacylglycerol analogue OAG (conventional PKC activator) (p<0.001). Conventional PKCs have a prominent role in NET formation. Furthermore PKCβ is the major isoform implicated in NET formation.

1 August 2013 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
AAAna L. Alessandri
Ana L. Alessandri
Lirlândia SousaLirlândia Sousa
Lirlândia Sousa
CLChristopher Lucas
Christopher Lucas
ARAdriano G. Rossi
Adriano G. Rossi
Vanessa PinhoVanessa Pinho
Vanessa Pinho
MTMauro M. Teixeira
Mauro M. Teixeira